Novo Nordisk, the company that makes Wegovy and Ozempic, is abruptly ousting its chief executive over concerns the firm is losing ground in the popular weight-loss drug market. The firm's market value ...

The billionaires are panicking in the first trailer for "Mountainhead," Jesse Armstrong's upcoming directorial debut. Written ...

Microfinance lender CreditAccess Grameen has swung back to black with its fourth quarter net profit being at Rs 47.2 crore as ...

Search funds are emerging as a new path to entrepreneurship in India, allowing professionals to acquire and grow existing ...

A drama from Spain about an ailing media mogul who turns on his children (sound familiar?) These are just some of the excellent shows and films available to stream right now. But with so much on offer ...

Novo Nordisk announces CEO transition as Lars Fruergaard Jørgensen departs amid Wegovy market share losses to Zepbound and ongoing supply chain disruptions ...

With an aging defensive leader approaching the latter stages of his career, one of South Africa's biggest clubs is reportedly looking to secure a promising young talent as part of their succession ...

Wrexham have punched above their weight in the transfer market, arming manager Phil Parkinson with a succession of teams capable of three successive promotions from the National League to the ...

Jorgensen became CEO in January 2017 and the company’s market capitalization has more than tripled during his tenure. Novo was first to market with Wegovy and its sister drug Ozempic for diabetes, but ...

The Albanese government’s convincing election win grants it a mandate, but it equally gives it the capital to fix broken ...

For farm families, estate taxes aren’t just an abstract policy debate -- they’re a very real threat to generational farms and ...

Warren Buffett, 94, attributed his decision to step down as Berkshire Hathaway's CEO to declining energy levels, rather than ...